Outlining the Landscape in Paediatric Glioma & Delving Into Recent Successes

Time: 9:15 am
day: Conference Day 1


  • Highlighting opportunities and challenges in developing therapeutics for elapsed or progressive paediatric low-grade glioma (pLGG).
  • Navigating the dual challenges of a shifting landscape for response assessment criteria and changing views on minor response as evidence of clinical benefit.
  • Targeting beyond the MAPK in paediatric glioma.